Big Money Sentiment decreased to 1.12 in Q4 2018. It has change of 0.18, from 2018Q3’s 1.3. The ratio fall due to Cohen & Steers, Inc. positioning: 14 sold and 43 reduced. 21 funds bought positions and 43 increased positions. Investors holded 21.23 million in 2018Q3 but now own 20.48 million shares or 3.54% less.
Invesco reported 0% of its capital in Cohen & Steers, Inc. (NYSE:CNS). Aperio Gru Ltd Liability Corporation holds 0% or 23,070 shs in its capital. The Illinois-based First Tru Advsrs L P has invested 0% in Cohen & Steers, Inc. (NYSE:CNS). 49,655 are owned by Millennium Mngmt Lc. Susquehanna Intl Gp Ltd Liability Partnership accumulated 6,854 shs. Glenmede Trust Na holds 0% of its capital in Cohen & Steers, Inc. (NYSE:CNS) for 24 shs. Moreover, Brown Advisory Inc has 0% invested in Cohen & Steers, Inc. (NYSE:CNS). State Of Alaska Department Of Revenue holds 0% of its capital in Cohen & Steers, Inc. (NYSE:CNS) for 2,877 shs. Gabelli & Com Investment Advisers accumulated 0.05% or 10,000 shs. First Hawaiian Natl Bank stated it has 0% of its capital in Cohen & Steers, Inc. (NYSE:CNS). Raymond James And Associates holds 47,877 shs or 0% of its capital. Moreover, California State Teachers Retirement Systems has 0% invested in Cohen & Steers, Inc. (NYSE:CNS) for 36,163 shs. Morgan Stanley reported 62,619 shs or 0% of all its holdings. Copeland Capital Limited Company stated it has 1.35% in Cohen & Steers, Inc. (NYSE:CNS). Prelude Mngmt Limited Co has 175 shs.

Cohen & Steers, Inc. (NYSE:CNS) Ratings Coverage

In total 2 analysts cover Cohen \u0026 Steers (NYSE:CNS). “Buy” rating has 0, “Sell” are 1, while 1 are “Hold”. 0 are bullish. 3 are the (NYSE:CNS)’s analyst reports since January 25, 2019 according to StockzIntelligence Inc. On Friday, January 25 the firm earned “Market Perform” rating by Wood. The company rating was downgraded by Keefe Bruyette & Woods on Wednesday, February 20. Listed here are Cohen & Steers, Inc. (NYSE:CNS) PTs and latest ratings.

01/03/2019 Broker: BidaskScore Rating: Buy Upgrade
20/02/2019 Broker: Keefe Bruyette & Woods Rating: Sell New Target: $36 Downgrade
25/01/2019 Broker: Wood Old Rating: Underperform New Rating: Market Perform Old Target: $31 New Target: $36 Upgrade

CNS is hitting $41.42 during the last trading session, after decreased 0.07%.Cohen & Steers, Inc. is uptrending after having risen 10.76% since March 16, 2018. CNS has 207,558 volume or 53.35% up from normal. The stock outperformed the S&P500 by 6.39%.

Cohen & Steers, Inc. is a publicly owned asset management holding company.The firm is worth $1.96 billion. Through its subsidiaries, the firm provides its services to institutional investors, including pension funds, endowments, and foundations.The P/E ratio is 17.26. It manages separate client-focused equity, fixed income, multi-asset, and commodity portfolios through its subsidiaries.

For more Cohen & Steers, Inc. (NYSE:CNS) news brought out briefly go to: Globenewswire.com, Seekingalpha.com, Seekingalpha.com, Zacks.com or Prnewswire.com. The titles are as follows: “Report: Exploring Fundamental Drivers Behind Square, American Midstream Partners, LP, Cohen & Steers, Kinder Morgan, ManTech International, and Delta Air Lines — New Horizons, Emerging Trends, and Upcoming Developments – GlobeNewswire” brought out on December 06, 2018, “4 Reasons To Avoid Cohen & Steers – Seeking Alpha” on January 28, 2019, “Cohen & Steers (CNS) CEO, Robert Steers on Q4 2018 Results – Earnings Call Transcript – Seeking Alpha” with a publish date: January 24, 2019, “Bull of the Day: GW Pharmaceuticals (GWPH) – Zacks.com” and the last “FDA Regulations Allow Medical Devices Clinical Trials to Differ From Pharmaceutical Trials – PRNewswire” with publication date: March 08, 2019.